Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Risk Assessment generated by a regulatory process
(RA)
published: 20 May 2020
last updated: 22 Apr 2021
Summary of risk assessment report on the Application for the evaluation of transgenic Gypsophila paniculata (Baby's Breath) Containing Pap-1 Gene for pink flower colour stability at a CFT facility at Beauty Line Farm, Naivasha, Kenya.
EN
09 Dec 2013
-
Competent National Authority:National Biosafety Authority ()NACOSTI Building, Loresho, off Waiyaki WayNairobi, Nairobi
28251--00100, KenyaPhone: (+254) (20) (2678667),Fax:Email: info@biosafetykenya.go.ke,Website: https://www.biosafetykenya.go.ke/,
-
Gypsophila modified for altered flower colour| Imaginature Ltd | Changes in quality and/or metabolite content (Flavonoids (e.g. anthocyanin), Pigmentation / Coloration), Selectable marker genes and reporter genes
- National Biosafety Authority [ English ]
- Risk assessment summary for Gypsophila.pdf [ English ]
EN
- Gypsophila-Decision Document.pdf [ English ]
